TYK Medicines, Inc (HKG: 2410)

TYK Medicines Statistics

Total Valuation

TYK Medicines has a market cap or net worth of HKD 17.80 billion. The enterprise value is 17.76 billion.

Market Cap	17.80B
Enterprise Value	17.76B

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

TYK Medicines has 370.84 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	370.84M
Shares Change (YoY)	n/a
Shares Change (QoQ)	+1.64%
Owned by Insiders (%)	2.22%
Owned by Institutions (%)	16.56%
Float	140.10M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-38.63
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-59.40

Financial Position

The company has a current ratio of 0.14

Current Ratio	0.14
Quick Ratio	0.11
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	-0.43
Interest Coverage	-35.63

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Capital (ROIC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	-3.19M
Employee Count	144
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	36.11
200-Day Moving Average	n/a
Relative Strength Index (RSI)	57.27
Average Volume (20 Days)	127,427

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-370.49M
Pretax Income	-460.80M
Net Income	-459.82M
EBITDA	-354.89M
EBIT	-370.49M
Earnings Per Share (EPS)	-1.51

Balance Sheet

The company has 170.10 million in cash and 129.71 million in debt, giving a net cash position of 40.39 million or 0.11 per share.

Cash & Cash Equivalents	170.10M
Total Debt	129.71M
Net Cash	40.39M
Net Cash Per Share	0.11
Equity (Book Value)	-1.12B
Book Value Per Share	-3.03
Working Capital	-1.30B

Cash Flow

In the last 12 months, operating cash flow was -251.20 million and capital expenditures -47.84 million, giving a free cash flow of -299.04 million.

Operating Cash Flow	-251.20M
Capital Expenditures	-47.84M
Free Cash Flow	-299.04M
FCF Per Share	-0.81

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TYK Medicines does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	n/a
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a